Monogram Technologies Inc. has announced an update to its merger agreement with Zimmer Biomet Holdings, Inc. The update involves a First Amendment to the Agreement and Plan of Merger, responding to a comment from the Securities and Exchange Commission. This amendment specifically modifies the definition of "Permitted Transfer" in the Form of CVR Agreement. Monogram Technologies Inc. will continue as a wholly-owned subsidiary of Zimmer Biomet Holdings following the merger.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Monogram Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-25-084127), on August 28, 2025, and is solely responsible for the information contained therein.